GTHP
Guided Therapeutics, Inc. [GTHP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GTHP Stock Summary
In the News
GTHP Financial details
Company Rating
-
Market Cap
5.09M
Income
-3.59M
Revenue
98K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-1.6
Forward P/E
-
PEG
0.3
P/S
119.92
P/B
-2.47
P/C
-
P/FCF
-5.21
Quick Ratio
0.15
Current Ratio
0.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-54.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-41.78%
Revenue last 5Y
22.18%
Revenue Q/Q
-
EPS Q/Q
-46.21%
-
-
-
-
SMA20
-
SMA50
-30.77%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
-301%
ROE
178%
ROC
1.33%
Gross Margin
-64%
Oper. Margin
-5157%
Profit Margin
-7422%
Payout
-10%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.062-0.3
52W High
-
52W Low
-
RSI
52.59
Rel Volume
0.85
Avg Volume
24.06K
Volume
20.5K
Perf Week
25%
Perf Month
4.17%
Perf Quarter
-40.3%
Perf Half Y
-37.5%
-
-
-
-
Beta
0.339
-
-
Volatility
0.01%, 0.01%
Prev Close
4.17%
Price
0.1
Change
28.21%
Company Profile
- Volume Average 24.06K
- Market Capitalization 5.09M
- Employee 4
- CEO Dr. Mark L. Faupel Ph.D.
- Headquarters Norcross,GA,US
- IPO Date 2021-01-08
-
Website
https://www.guidedinc.com 
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
